Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,184 | 8,433 | -68,538 | -23,631 | -116,537 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 374 |
| Income taxes - deferred | 431 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,751 | N/A | 2,244 | 451 | -2,600 |
| Other Working Capital | 8,710 | 10,227 | 3,425 | 265 | -4,917 |
| Other Operating Activity | -27,979 | -46,944 | 46,354 | 14,174 | 84,153 |
| Operating Cash Flow | $-47,271 | $-28,284 | $-16,515 | $-8,741 | $-39,527 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -70,314 | -22,932 | -10,130 | 9,783 | -45,287 |
| Investing Cash Flow | $-70,314 | $-22,932 | $-10,130 | $9,783 | $-45,287 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 133,522 | 53,355 | 48,072 | 1 | 33,017 |
| Financing Cash Flow | $133,522 | $53,355 | $48,072 | $1 | $33,017 |
| Beginning Cash Position | 4,612 | 4,612 | 4,612 | 4,612 | 56,409 |
| End Cash Position | 20,549 | 6,751 | 26,039 | 5,655 | 4,612 |
| Net Cash Flow | $15,937 | $2,139 | $21,427 | $1,043 | $-51,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,271 | -28,284 | -16,515 | -8,741 | -39,527 |
| Free Cash Flow | -47,271 | -28,284 | -16,515 | -8,741 | -39,527 |